Cargando…
Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents
Although significant levels of side effects are often associated with their use, microtubule-directed agents that primarily target fast-growing mitotic cells have been considered to be some of the most effective anti-cancer therapeutics. With the hope of developing new-generation anti-mitotic agents...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497816/ https://www.ncbi.nlm.nih.gov/pubmed/28721210 http://dx.doi.org/10.12688/f1000research.11398.1 |